Research and Markets - Increased Need to Maximise Impact of Pharma-Patient Group Alliances Across Range of Pharma Activities

Research and Markets (researchandmarkets.com/reports/c9324) has announced the addition of Harnessing Patient Power: Strategies for speeding drug approval, building and retaining market share to their offering.

(PRWEB) November 17, 2004 -- Research and Markets (http://www.researchandmarkets.com/reports/c9324) has announced the addition of Harnessing Patient Power: Strategies for speeding drug approval, building and retaining market share to their offering.

Relationships between the pharmaceutical industry and patient groups have changed drastically during the past two decades, they are no longer restricted to financial contributions to create goodwill, with no expectation of a measurable return for the company. This management report outlines the developments in pharma-patient group alliances and provides a guide for maximizing their impact across a range of pharma activities: clinical trial recruitment, product launches, CME programs, disease awareness and education initiatives. Advocacy groups are now more aware of how to leverage their influence, but still seek financial assistance, cutting-edge information about clinical trials, new therapies, professional or technical support, and other in-kind contributions that help them better serve their patient communities. The report uses detailed case studies to pinpoint how pharma companies can convert such relationships into important business tools to meet their corporate objectives.

Topics Covered Include:

- An Introduction to Patient Power

Case study: Online CML support groups and Novartis Gleevec

Case study: Gilead Sciences Preveon

- Relationships Between Pharma

Case study: The Terrence Higgins Trust (UK)

Case study: Prostate Cancer Awareness Week (US)

Case study: Coalition of National Cancer Cooperative Groups (US)

Case study: American Medical Women's Association

Case study: aging patients

Case study: American Diabetes Association

Case study: The DoD Breast Cancer Research Project

Case study: The Breast Cancer Coalition (UK)

- Building Effective Relationships

Case study: Pharmacia and G.R.O.U.P.

Case studies: DTCI & DTP

-A Strategic Approach to Forming

Case study: the Health Coalition Initiative (UK)

- The Future Outlook

For more information visit http://www.researchandmarkets.com/reports/c9324

Laura Wood

Senior Manager

Research and Markets

press@researchandmarkets.com

Fax: +353 1 4100 980

###